tion in human hematopoiesis and chronic myeloid leukemia. Manukjan G, Ripperger T, Venturini L, Stadler M, Göhring G, Schambach A, Schlegelberger B, Steinemann D. Stem Cell Res. 2016 May;16(3):677-81.
Raad J, Durban A, Schiemann M, Könecke C, Diedrich H, Holler E, Beutel G, Krauter J, Ganser A, Stadler M: The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic
Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, Hösel M, Michler T, Wisskirchen K, Cheng X, Zhang K, Chou WM
Transduce Mature Human Adipocytes in Three-Dimensional Slice Cultures. Kallendrusch S, Schopow N, Stadler SC, Büning H, Hacker UT. Hum Gene Ther Methods. 2016 Oct;27(5):171-173. Evaluation of Angiopoietin-2
autoimmune Optikusneuritis nach Stammzelltransplantation Khalili Amiri S.*, Hufendiek K., Skripuletz T., Stadler M., Framme C., Hufendiek K . Ophthalmologe 2018 · 115(Suppl1):S1–S194; https://doi.org/10.1007/s
the number of hepatic leptin receptor (ob-R) expressing NK cells. Endocr Res. 2011;36(4):158-66. Stadler J, Le TP , Haas P, Nave H. Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of
Martin, Wiehlmann, Lutz, Lehmann, Ulrich, Koenecke, Christian, Chaturvedi, Anuhar, Alchalby, Haefaa, Stadler, Michael, Eder, Matthias, Christopeit, Max, Göhring, Gudrun, Koenigsmann, Michael, Schlegelberger
Storey M, Freed NE, Pattabiraman C, Prasad P, Desai AS, Vasanthapuram R, Schulz TF, Steinbruck L, Stadler T, Swiss Viollier Sequencing Consortium, Parisi A, Bianco A, Garcia de Viedma D, Buenestado-Serrano [...] Epidemiol 2023 DOI: 10.1007/s10654-022-00938-6 Jansen-Olliges L, Chatterjee S, Jia L, Stahl F, Bar C, Stadler M, Surup F, Zeilinger C. Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor [...] 2023 DOI: 10.1055/a-1985-0450 Göttig L., Weiss C, Stubbe M, Hanrieder L, Hofmann S, Grodziecki A, Stadler D, Carpentier A, Protzer U, Schreiner S. Apobec3A Deamination Functions Are Involved in Antagonizing
relapsed or refractory diffuse large B-cell lymphoma. Ann Nucl Med. 2021;35:132-138. HUEMMERT MW, STADLER M, HAMBACH L, GINGELE S, BREDT M, WATTJES MP, GOEHRING G, VENTURINI L, MOEHN N, STANGEL M, TREBST